GeneDx Holdings Corp.
WGS
$70.69
-$4.81-6.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.31% | 13.72% | |||
| Total Other Revenue | 15.00% | 12.23% | |||
| Total Revenue | 3.64% | 13.68% | |||
| Cost of Revenue | 13.97% | 1.34% | |||
| Gross Profit | -0.30% | 19.22% | |||
| SG&A Expenses | 6.79% | 44.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.52% | 28.02% | |||
| Operating Income | -294.65% | -136.28% | |||
| Income Before Tax | -146.75% | -169.94% | |||
| Income Tax Expenses | -328.34% | 200.41% | |||
| Earnings from Continuing Operations | -131.38% | -170.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -131.38% | -170.64% | |||
| EBIT | -294.65% | -136.28% | |||
| EBITDA | -312.50% | -78.73% | |||
| EPS Basic | -129.39% | -170.10% | |||
| Normalized Basic EPS | -222.62% | -142.32% | |||
| EPS Diluted | -129.39% | -173.64% | |||
| Normalized Diluted EPS | -222.62% | -144.06% | |||
| Average Basic Shares Outstanding | 0.88% | 0.76% | |||
| Average Diluted Shares Outstanding | 0.88% | -3.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||